Suicidality in women with Premenstrual Dysphoric Disorder: a systematic literature review by Osborn, E. et al.
REVIEW ARTICLE
Suicidality in women with Premenstrual Dysphoric Disorder:
a systematic literature review
E. Osborn1,2 & J. Brooks1 & P. M. S. O’Brien3 & A. Wittkowski1,2
Received: 2 April 2020 /Accepted: 16 July 2020
# The Author(s) 2020
Abstract
Previous research has identified how menstruation is an important factor in both attempted and completed suicides for women.
The purpose of this review was to outline (a) the risk profile for suicidality in women who were identified to experience
Premenstrual Dysphoric Disorder (PMDD), a condition characterized by severe physical and psychological changes that occur
during the luteal menstrual phase, and (b) the implications of these findings for clinical practice. A systematic literature review
was conducted using five databases to identify any peer-reviewed articles published between 1989 and 2019. Ten papers eligible
for inclusion were identified: three pertaining to suicide cognitions, five to suicide attempts and two to both cognitions and
attempts. Findings showed that suicidal thoughts, ideation, plans and attempts were strongly associated with experiences of
PMDD and that these findings were independent of psychiatric co-morbidities. However, women with PMDD did not present
with more severe risk profiles for suicide attempts (in terms of frequency, impulsivity and lethality) or make more frequent
attempts during the luteal menstrual phase compared with suicide attempters without PMDD. Women with PMDD should be
considered a high risk group for suicidality; thus, identifying and treating symptoms are vital in reducing suicide attempts.
Implications for clinical practice are outlined in the discussion.
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Introduction
Nearly 800,000 people die by suicide each year, a statistic that
equates to one life being lost every 40 seconds. For each
person who completes suicide, it is estimated that 20 others
will have made attempts, resulting in a potential figure of 16
million people worldwide (World Health Organization 2019).
Thus, suicide constitutes a major public health problem for
which understanding and preventing deaths have been identi-
fied as both local and global priorities (Department of Health
and Social Care 2012; World Health Organisation 2014
). With statistics consistently showing that women make more
frequent attempts to end their own lives than men
(Vijayakumar 2015), it is imperative that we further under-
stand the reasons underlying suicidal behaviours in women,
in order to inform future prevention and treatment.
The factors that drive an individual to suicide are often
complex and varied; however, there is an increasing body of
evidence that menstruation may play a significant role for
some women. Studies have identified how suicide attempts
in women are positively associated with particular menstrual
cycle phases (Jang and Elfenbein 2019; Papadopoulou et al.
2019; Zengin et al. 2015) and with fluctuating levels of the
female sex hormones oestrogen and progesterone (Mousavi
et al. 2014; Baca-Garcia et al. 2010). In addition to findings
for attempted suicide, several autopsy studies have also iden-
tified significantly increased incidences of completed suicides
during both the luteal and menses phases (Leenaars et al.
2009; Dogra et al. 2007), leading researchers to conclude that
menstrual-related changes are an important mediating factor.
Mild changes in mood are commonly reported by women
prior to the onset of menses, with estimates that four in ten
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women experience symptoms of premenstrual syndrome (PMS;
Green et al. 2017), also known as premenstrual tension (PMT).
Both PMS and PMT are umbrella terms for a variety of physical
and emotional changes that occur in the lead up to a menstrual
bleed and can include symptoms of depression and anxiety,
alongside reduced confidence and feelings of irritability (Green
et al. 2017). Whilst the research literature is limited, a review of
44 studies into suicide and the menstrual cycle by Saunders and
Hawton (2006) identified a significant association between ex-
periences of PMS and suicide attempts in women, based upon
the findings of three papers. In particular, the researchers cited the
findings of Chaturvedi et al. (1995) who identified PMS as a risk
category for suicidal behaviours and concluded that thesewomen
should be considered a high suicidal risk.
For a small minority of women, the emotional changes expe-
rienced prior to the onset of menses can be extremely severe.
Premenstrual Dysphoric Disorder (PMDD) is a chronic health
condition affecting 3–8% of women of menstruating age
(Halbreich et al. 2003) and is characterized by debilitating cog-
nitive, affective and behavioural changes that occur during the
luteal menstrual phase and typically remit following the onset of
menses (Braverman 2007). Originally termed as Late Luteal
Phase Dysphoric Disorder (LLPDD) due to its cyclical nature
(Diagnostic and Statistical Manual of Mental Disorders; DSM-
III-R; American Psychiatric Association, 1987), and sometimes
referred to as “severe PMS”, PMDD was renamed in 1994
(DSM-IV; American Psychiatric Association, 1994), with diag-
nosis requiring a specific pattern of symptoms that are differenti-
ated in both severity and impact from PMS, thus capturing a
distinct clinical entity and a much more severely afflicted catego-
ry of women (see Table 1 for DSM-5 PMDD diagnostic criteria).
With quality of life estimates presenting as comparable with
that of other chronic illnesses (Halbreich et al. 2003; Rapkin
and Winer 2009) and findings that it can take an average of
20 years for women’s symptoms to be accurately diagnosed
and treated (Osborn et al. 2020), the burden for individuals
living with PMDD is huge. Recent survey data indicated that
30% of women with PMDD reported attempts to end their own
life (Eisenlohr-Moul et al. 2019); thus, women with this condi-
tion are likely to be a highly vulnerable population.
Previous reviews have provided an overview of what is
known about PMDD, including the epidemiology and treat-
ment options (Hantsoo and Epperson 2015; Cunningham et al.
2009; Sepede et al. 2016), alongside reviewing the potential
mechanisms by which the menstrual cycle may increase sui-
cide risk (Owens and Eisenlohr-Moul 2018). However, to
date, no review has focussed specifically on reviewing the
available data for experiences of suicidality in women
PMDD, despite the importance of understanding the risks
for this particular subgroup.
By synthesizing the available data, this review aimed to
outline the risk profile for suicidality in women of menstruating
age identified to experience PMDD, LLPDD or PMS that is
further defined as “severe” or “extreme” and to consider how
these findings compared with both the general population and
women with PMS. Suicidality in this context is used broadly to
refer to a spectrum of markers from suicidal thoughts, ideation
and plans, through to suicide attempts.
Method
Search strategy
A systematic review of the literature was conducted using
EMBASE, CINAHL, MEDLINE, PsycINFO and Web of
Table 1 DSM-5 diagnostic criteria for PMDD
Timing of symptoms
A) In the majority of menstrual cycles, at least 5 symptoms must be
present in the final week before the onset of menses, start to improve
within a few days after the onset of menses and become minimal or
absent in the week post menses
Symptoms
B) One or more of the following symptoms must be present:
1) Marked affective lability (e.g. mood swings, feeling suddenly sad or
tearful or increased sensitivity to rejection)
2) Marked irritability or anger or increased interpersonal conflicts
3) Markedly depressed mood, feelings of hopelessness or
self-deprecating thoughts
4) Marked anxiety, tension and/or feelings of being keyed up or on edge
C) One (or more) of the following symptomsmust additionally be present
to reach a total of 5 symptoms when combined with symptoms from
criterion B above:
1) Decreased interest in usual activities
2).Subjective difficulty in concentration
3) Lethargy, easy fatigability or marked lack of energy
4) Marked change in appetite; overeating or specific food cravings
5) Hypersomnia or insomnia
6) A sense of being overwhelmed or out of control
7) Physical symptoms such as breast tenderness or swelling; joint or
muscle pain, a sensation of “bloating” or weight gain
Severity
A. D) The symptoms are associated with clinically significant distress or
interference with work, school, usual social activities or relationships
with others
B. E) Consider Other Psychiatric Disorders. The disturbance is not
merely an exacerbation of the symptoms of another disorder, such as
major depressive disorder, panic disorder, persistent depressive
disorder (dysthymia) or a personality disorder (although it may
co-occur with any of these disorders)
Confirmation of the disorder
F) Criterion A should be confirmed by prospective daily ratings during at
least 2 symptomatic cycles (although a provisional diagnosis may be
made prior to this confirmation). Exclude other Medical Explanations
G) The symptoms are not attributable to the physiological effects of a
substance (e.g. drug abuse, medication or other treatment) or another
medical condition (e.g. hyperthyroidism)
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Science on December 2, 2019. The search terms used to iden-
tify relevant papers are detailed in Table 1. Results were lim-
ited to papers published between 1989 and 2019. Figure 1,
based on the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines (Moher
et al. 2009), illustrates the selection process.
Inclusion and exclusion criteria
The inclusion criteria were (1) English language; (2) pub-
lished in a peer-reviewed journal, (3) pertaining to experiences
of suicidality in women of menstruating age who met the
criteria for (a) PMDD, (b) LLPDD or (c) severe or extreme
PMS; and (4) gathered or analysed empirical data. Reviews
and single case study papers were excluded. The first 50% of
studies (n = 157) were independently screened for inclusion
by a peer (CP), which yielded a perfect rate of agreement
(100%). Table 2 shows the search terms used.
Synthesis
Key characteristics from the studies were extracted and tabu-
lated (see Table 3). Findings were then synthesized into a
discursive narrative review to provide an overview of the
available data.
Assessment of methodological quality and risk of bias
In order to provide an indication of the methodological bias
inherent in each study, the included papers were assessed
using the Quality Assessment Tool for Studies with Diverse
Designs (QATSDD; Sirriyeh et al. 2012). Thirteen items rel-
evant to quantitative studies were rated on a 4-point scale,
from “not at all” (0) to “complete” (3), and percentage scores
were calculated based on the actual score and the maximum
total score. A random 50% of studies were assessed by an
independent peer (GCY); the kappa score for the interrater
10 articles included after full text 
screening
31 articles excluded, with reasons: 
Conference abstract only n = 4
Case study n = 6
Not English n = 1
Unpublished thesis n = 2
Did not gather or analyse 
empirical data n = 6
Review n = 4
PMS not further defined as 
Severe/Extreme n = 1
Ineligible analysis of suicide 
data for PMDD/Severe PMS 






542 records identified through 
database searching   
CINAHL (50), Medline (74), 
PsycINFO (72), Embase (233), 
Web of Science (113)
228 duplicates
excluded
























0 from citation searches of 
included papers
10 papers included in final 
review
Fig. 1 Flowchart demonstrating
the literature review procedure
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reliability was 0.88, indicating an “almost perfect” level of
agreement (see Table 3 for study ratings).
Results
Selection of studies
The search strategy identified 542 references. After removing
duplicates, the titles and abstracts of 314 articles were
screened for inclusion. Forty-one potentially relevant papers
were identified for full-text evaluation, but 31 papers were
subsequently excluded (see Fig. 1). Ten studies met inclusion
criteria and were included in this review.
Study and participant characteristics
Included articles were published between 2002 and 2018 and
originated from nine different countries. No papers pertaining
to LLPDD or “severe” or “extreme” PMS and suicidality were
identified; thus, this review pertains solely to the current clas-
sification of PMDD. Of the ten papers included, three studies
utilized a case control design, four were epidemiological co-
hort studies, and three were cross-sectional studies of identi-
fied patient groups (see Table 3).
Participants comprised of 10,951 women aged between 13
and 53 years, including 281 control participants (2.6%). From
these women, 725 (6.6%) were identified to have PMDD (see
Table 3); however, Yonkers et al. (2003) did not report the
prevalence data for PMDD within their sample.
Quality assessment
QATSDD scores for the included articles ranged between
38.5 and 79.5%, with a mean average of 60.3%. Yonkers
et al. (2003) obtained the lowest score, due to limited meth-
odological descriptions and a lack of clarity regarding several
key criteria. In total, one paper was rated as having “excellent”
quality, seven as “good” and two as “moderate”. As this is the
first review to evaluate suicidality in women with PMDD, all
studies were included in the final synthesis in order to provide
a comprehensive overview of the available research.
PMDD diagnosis
Nine studies reported that participants were assessed for
PMDD based upon the diagnostic criteria outlined in the
DSM, using variable methods (see Table 3 for an overview).
Yonkers et al. (2003) reported using a questionnaire that was
designed specifically for their study. However, as prospective
charting of two symptomatic cycles is required for full DSM
diagnosis, PMDD diagnoses should be considered provisional
for all studies included in this review.
Assessment of suicidality
Suicidality was assessed using structured diagnostic inter-
views (n = 5), standardized questionnaires (n = 1) and state-
ments about suicide for which affirmative responses were
scored (n = 1). In addition, three studies recruited women from
a hospital following a suicide attempt (see Table 3).
Summary of suicidality findings
Findings were grouped according to the type of suicidality
being reported, including suicide cognitions (n = 5) and sui-
cide attempts (n = 7). Of the ten studies included in this re-
view, two studies reported data pertaining to both cognitions
and attempts and therefore featured in both groupings.
Supplementary data relating to PMS comparison groups, sui-
cide risk profiles (in terms of frequency, impulsivity and se-
verity), the influence of Axis I disorders and menstrual cycle
phase were also summarized.
Study findings
Suicide cognitions
In 2018 de Carvalho et al. reported findings from 727
Brazilian women, identifying that women with PMDD (n =
128) were two or three times more likely to report “current
suicide risk” (p.45), compared with women without PMDD.
Whilst the authors did not further specify the suicide features
that constituted “risk”, several studies have reported data
showing that women with PMDD described increased suicide
cognitions, including suicidal thoughts, ideation and plans.
Table 2 Search terms used in the
systematic literature search Category Search terms
Patient/problem Premenstrual Dysphoric Disorder OR PMDD OR Premenstrual Syndrome OR PMS or
Premenstrual Tension OR PMT OR Late Luteal Phase Dysphoric Disorder ORMenstrual
Cycle* OR Menstrual Disorder*
Outcome Suicidality OR Suicidal Ideation OR Suicide OR Suicide Attempt ORAttempted Suicide OR
Suicidal Thoughts OR Suicidal Behav*















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































179Suicidality in women with Premenstrual Dysphoric Disorder: a systematic literature review
First, Yonkers et al. (2003) assessed 907 women in
Connecticut, USA. The researchers found that 24% of women
with PMDD endorsed suicidal thoughts at any level (several
days, more than half of the days or every day) and that 20% of
these women endorsed suicidal thoughts for several days.
Data pertaining to suicidal ideation and plans were reported
by three further studies. Both Hong et al. (2012) and Pilver
et al. (2013) analysed data from large epidemiological studies
based in South Korea and the USA, respectively. Together,
these studies included data from 6464 women aged between
18 and 49 years, from which 227 women (3.5%) were identi-
fied to experience PMDD. The frequency of suicidal ideation
and plans was analysed among PMDD and non-PMDD cases,
and data were reported for both 12-month prevalence (Hong
et al. 2012) and lifetime prevalence (Hong et al. 2012; Pilver
et al. 2013).
In both studies, the researchers identified that women with
PMDD were significantly more likely to report suicidal idea-
tion and plans, compared with women without PMDD.
Prevalence rates for lifetime suicidal ideation in women with
PMDD were 45.8% and 37.4%, compared with 17.3% and
13.3% for women without PMDD, respectively (Hong et al.
2012; Pilver et al. 2013). Likewise, prevalence rates for sui-
cide plans in women with PMDD were 16.9% and 19.1%,
compared with 4.2% and 4.6% for women without PMDD,
respectively (Hong et al. 2012; Pilver et al. 2013). In addition
to a significant lifetime prevalence, Hong et al. (2012) also
identified a significant 12-month prevalence of both suicidal
ideation and plans, findings that were independent of social
desirability and demographic covariates.
Furthermore, Ogebe et al. (2011) reported findings for ad-
olescents aged between 13 and 21 years. In this study, the
researchers identified that 18% of adolescents with PMDD
reported suicidal ideation, in comparison with 10.9% of ado-
lescents with no or mild PMS symptoms. In sum, womenwith
PMDD are significantly more likely than women without
PMDD to endorse suicide cognitions and therefore present
an increased risk for suicidality. Importantly, these findings
were not limited by age, social desirability or demographic
covariates and were reported across a mixture of America,
African and Asian cultures.
Suicide attempts
Data pertaining to suicide attempts were reported in seven
studies and were further defined into self-report data (n = 4)
and hospital admissions data (n = 3).
Self-report data Wittchen et al. (2002) explored the preva-
lence and co-morbidities of PMDD in a community sample
of 1488 young women, living in Munich, Germany. During
their analysis, the authors identified a “remarkably high risk”
(p.128) of suicide attempts among PMDD cases (n = 112),
with 15.8% reporting at least one suicide attempt during their
lifetime, compared with a frequency of 3.2% for women with-
out PMDD. Since these findings, three further studies have
reported similar observations.
In their epidemiological studies, Hong et al. (2012) and
Pilver et al. (2013) also assessed participants for a history of
suicide attempts and identified a significantly higher preva-
lence of previous suicide attempts of 13.6% and 16.2% re-
spectively in women with PMDD, compared with women
with no premenstrual symptoms (Hong et al. 2012: 3.9%;
Pilver et al. 2013: 4.9%). Soydas et al. (2014) compared 70
Turkish women with PMDD to a healthy control group and
identified a significantly higher frequency of historical suicide
attempts in the PMDD group (7.1%) compared with the con-
trol group (0%). Thus, findings consistently show that women
with PMDD are significantly more likely than womenwithout
PMDD to self-report previous suicide attempts.
Hospital admissions data Three studies assessed the preva-
lence of PMDD among women who had been admitted to
the hospital following a suicide attempt. In the first study,
Baca-Garcia et al. (2004) assessed 125 women who were ad-
mitted to the emergency room of a Spanish general hospital
following a suicide attempt and compared them with 83 fe-
male blood donor controls: 54% of the women who had
attempted suicide met the diagnostic criteria for PMDD (67/
125), in contrast to just 6% (5/83) of the control group.
Ducasse et al. (2016) collected data from 232 women consec-
utively hospitalized in a French psychiatric unit following a
suicide attempt and found that 23% retrospectively met the
diagnostic criteria for PMDD (51/232). Finally, Shams-
Alizadeh et al. (2018) studied 120 women admitted to a gen-
eral hospital in Iran following a suicide attempt comparedwith
a matched control group. In accordance with the previous
findings, the researchers identified that PMDD was signifi-
cantly more frequent in women who had attempted suicide
(30.8%; 37/120), compared with the control group (5%;
6/120).
In summary, women with PMDD are significantly more
likely to self-report previous suicide attempts, compared with
women without PMDD. In addition, hospital admission stud-
ies show that a remarkably high proportion of female suicide
attempters retrospectively met the criteria for PMDD.
Comparison with PMS
Pilver et al. (2013) identified that women with PMDD were
significantly more likely to report suicidal ideation (37.4%),
plans (19.1%) and attempts (16.2%) compared with women
with PMS (22%, 7.6% and 7.4%, respectively). Likewise,
Shams-Alizadeh et al. (2018) found that PMDD was signifi-
cantly more frequent in a group of female suicide attempters
compared with a control group, whilst no differences were
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identified in the prevalence of PMS between the two groups.
However, Ogebe et al. (2011) identified that 24% of adoles-
cents with PMS reported suicidal ideation, compared with just
18% of adolescents with PMDD. Thus, whilst there is some
evidence to support an increased risk profile for women with
PMDD, findings to date are contradictory and require further
research.
Suicide attempt risk profiles
Data pertaining to the frequency, impulsivity and lethality of
suicide attempts were reported by both Baca-Garcia et al.
(2004) and Ducasse et al. (2016). Their findings showed that
women with PMDD who had attempted suicide did not exhibit
amore severe risk profile comparedwith suicide attempters with-
out PMDD. Although Baca-Garcia et al. (2004) identified that
59% of women with PMDD had made a previous suicide at-
tempt and that 32% had made more than two previous attempts,
these findings were not significantly different to the frequencies
reported by non-PMDD cases. Likewise, no significant differ-
ences were identified regarding the impulsivity of suicide at-
tempts between women with and without PMDD in either study,
or regarding the lethality of suicide attempts.
Influence of Axis I disorders
Psychiatric co-morbidities are commonly experienced bywomen
with PMDD; therefore, it is important to establish whether the
relationship identified between PMDD and suicidality exists in-
dependently. Several studies included in this review reported data
that controlled for the presence of co-morbid Axis I psychiatric
disorders, with findings showing that the relationships between
PMDD and suicidality largely remained significant after these
adjustments were made. Specifically, Pilver et al. (2013) identi-
fied that the strong associations between PMDD and suicidal
ideation, plans and attempts were independent of psychiatric
co-morbidity, Wittchen et al. (2002) identified that suicide at-
tempts in womenwith PMDD remained significant after control-
ling for major depressive disorders, and Hong et al. (2012) iden-
tified that both lifetime and 12-month suicidal ideation remained
significant, when adjustments for psychiatric disorders were
made, although significant associations with suicide plans and
attempts disappeared.
Relationship to menstrual cycle phase
With PMDD symptoms commencing during the week(s) prior
to the onset of menses, it would be anticipated that there
would be an increased frequency of suicide attempts during
the luteal menstrual phase for women with PMDD. However,
Baca-Garcia et al. (2004), Ducasse et al. (2016) and Shams-
Alizadeh et al. (2018) all reported finding no differences in
cycle phase between suicide attempters with and without a
retrospective diagnosis of PMDD. Thus, despite the signifi-
cant associations identified between PMDD and suicidality,
women with PMDD did not seem to be more likely to attempt
suicide during the luteal menstrual phase, when symptoms are
expected to reach peak severity.
Discussion
This is the first systematic review to report on the suicidal expe-
riences of women who were identified to have Premenstrual
Dysphoric Disorder (PMDD). Findings showed that suicidal
thoughts, ideation, plans and attempts were strongly associated
with experiences of PMDD. These findings appeared indepen-
dent of psychiatric co-morbidities and were identified using a
variety of methodologies. However, no significant differences
were identified between PMDD and non-PMDD cases regarding
suicide attempt risk profiles in terms of frequency, impulsivity or
lethality or menstrual cycle phase. These findings provide further
evidence to substantiate important associations between themen-
strual cycle and suicidality and offer new insights into the risk
profiles for women with PMDD.
Owing to the significant relationship previously identified be-
tween PMS and suicidality (Saunders and Hawton 2006), our
findings of positive associations between PMDD and both
suicide cognitions and attempts were expected, given that the
current review focussed upon a more severely afflicted
population. Likewise, findings by Pilver et al. (2013) of a signif-
icantly increased prevalence of suicidal experiences in women
with PMDD, comparedwith womenwith PMS, provided further
indication of the vulnerability of this particular subgroup.
However, the inconsistencies in data reported by Ogebe et al.
(2011) highlight how this is an area that requires further research.
In contrast, findings of a lack of association between suicide
attempts and the luteal menstrual phase, alongside the remark-
ably high prevalence of PMDD in female suicide attempters
admitted to hospital, were unexpected.
With PMDD symptoms typically occurring during the week
prior to the onset of menses, women with PMDD would be
expected to attempt suicide more often during the luteal menstru-
al phase, when their symptoms reached peak severity. However,
this review identified no differences in menstrual cycle phase
between suicide attempters with and without PMDD. Whilst
these results were surprising, they may be explained by a
recent study byOsborn et al. (2020)who identified that, for some
women, PMDD symptoms were experienced for up to 3 weeks
prior to the onset of menses, rather than being confined solely to
the week prior to menstruation, as is often cited. Thus, future
research assessing the daily severity of both PMDD symptoms
and suicidality, alongside the women’s menstrual phase, would
be beneficial in further exploring this relationship.
Whilst no differences were identified between PMDD and
non-PMDD cases with regard to the impulsivity of suicide
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attempts in this review, additional findings reported by Baca-
Garcia et al. (2004) identified differences in personality trait level
impulsivity between the two groups. Importantly, women with
PMDDwere found to have significantly more impulsive traits on
the Barratt Impulsivity Scale (BIS; Patton et al. 1995) compared
with the control group; however, this finding became non-
significant following Bonferroni correction. Nonetheless, the re-
searchers identified a possibility that PMDD is a risk factor for
suicidal behaviour due to an association with impulsivity.
Subsequent research has confirmed heightened levels of impul-
sivity with both PMDD and premenstrual symptom severity (e.g.
Dawson et al. 2018; Petersen et al. 2016), making this a hypoth-
esis that would benefit from future research. Future research
should also be directed at the clinically most meaningful assess-
ment of impulsivity in this group of women and its role as a
potential risk factor alongside the role that personality traits
may play. It should be noted that the majority of studies included
in this review reported that women with co-existing psychiatric
disorders were excluded from their samples. Finally, the influ-
ence of age on suicidality in relation to PMDD warrants further
investigation.
Limitations of this review and the included studies
The inclusion criteria for this review specified English lan-
guage and peer-reviewed articles only. Whilst only one for-
eign language study was excluded, we acknowledge that the
introduction of language and publication biases is a possible
limitation of this review.
Furthermore, it is important to acknowledge that for all of
the studies included in this review, diagnoses of PMDD were
both provisional and retrospective. In order to meet DSM
criteria for PMDD, women are required to complete prospec-
tive daily ratings of their symptoms during at least two symp-
tomatic menstrual cycles (American Psychiatric Association,
DSM-5 2013).Whilst prospective charting would have placed
considerable additional demands on study participants, it
would have greatly strengthened the validity of the reported
data, given that women’s retrospective recall of premenstrual
symptoms is considered unreliable (Dell 2004).
Notably, several studies in this review identified preva-
lence statistics that were substantially larger than typical pop-
ulation estimates for PMDD of between 3 and 8% (Halbreich
et al. 2003). For example, de Carvalho et al. (2018) reported a
PMDD prevalence rate of 17.6% in a sample of young
Brazilian women. These findings indicate that samples may
have included women who experienced the less severe symp-
toms of PMS and may reflect differences in the assessment
methods and psychometric tools that were used by the studies.
Thus, all results pertaining to provisional PMDD diagnoses in
this review should be interpreted with caution.
Although significant associations were identified between
PMDD and suicidal thoughts, ideations, plans and attempts, the
findings of this review are unable to infer causality.Women who
attempt suicide likely do so for many reasons and the data
outlined here indicates that PMDD is only one factor. Whilst
several studies reported controlling for the presence of psychiat-
ric co-morbidities, we acknowledge the difficulty in achieving
this, given the considerable overlap between PMDD symptoms
and common mental health disorders. As previously mentioned,
the majority of included studies excluded women with any co-
existing psychiatric disorders. The challenge for clinicians of
discerning between a treatable health condition and other
severe psychiatric conditions has been discussed by Osborn
et al. (2020) and, combined with the findings of this review,
highlights the clinical complexities associated with this condition
and the potential for devastating outcomes. Finally, the findings
of this review cannot account for instances of completed suicide
in women with PMDD. Whilst there are many examples of
autopsy studies investigating the menstrual phase of women
who have lost their lives to suicide (e.g. Leenaars et al. 2009;
Dogra et al. 2007; Chetankumar and Kokatanur 2016), to date,
there are no such studies looking at the associations between
completed suicide and PMDD; thus, this review pertains to
non-fatal suicidality only.
Implications for clinical practice
Owing to the strong relationships identified between PMDD and
suicidality in this review and the high levels of PMDD identified
in female suicide attempters, there is an obligation on clinicians
to consider hormonal explanations for all women who endorse
suicidal thoughts, ideation, plans or attempts. In clinical practice,
the premenstrual symptomology of women who report or at-
tempt suicide should be routinely assessed using a clinical assess-
ment and/or a brief standardized screening measure, such as the
Premenstrual Symptoms Screening Tool (PSST; Steiner et al.
2003), alongside encouragingwomen to prospectively chart their
symptoms and experiences. Upon PMDD being identified, it is
imperative that appropriate support and treatments are available
for women in order to reduce suicide attempts and the likelihood
of subsequent unnecessary deaths.
Conclusions
Women with PMDD should be considered a high-risk group for
suicidality, including increased vulnerabilities for suicidal
thoughts, ideation, plans and attempts. Detecting and treating
PMDD symptoms is of paramount importance in order to reduce
suicide attempts and save women’s lives; thus, the routine
screening of all women who present with suicidality is
encouraged.
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